Philip W. Loberg
2011
In 2011, Philip W. Loberg earned a total compensation of $1.4M as Executive Vice President, Interim Chief Financial Officer at Valeant Pharmaceuticals International, a 102% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $500,000 |
|---|---|
| Salary | $463,084 |
| Stock Awards | $418,875 |
| Other | $41,785 |
| Total | $1,423,744 |
Loberg received $500K in non-equity incentive plan, accounting for 35% of the total pay in 2011.
Loberg also received $463.1K in salary, $418.9K in stock awards and $41.8K in other compensation.
Rankings
In 2011, Philip W. Loberg's compensation ranked 4,405th out of 10,747 executives tracked by ExecPay. In other words, Loberg earned more than 59.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,405 out of 10,747 | 59th |
Division Manufacturing | 1,562 out of 3,960 | 61st |
Major group Chemicals And Allied Products | 321 out of 1,033 | 69th |
Industry group Drugs | 192 out of 781 | 75th |
Industry Pharmaceutical Preparations | 150 out of 571 | 74th |
Source: SEC filing on April 30, 2012.
Loberg's colleagues
We found six more compensation records of executives who worked with Philip W. Loberg at Valeant Pharmaceuticals International in 2011.
2011
J Pearson
Valeant Pharmaceuticals International
Chief Executive Officer
2011
Howard Schiller
Valeant Pharmaceuticals International
Chief Financial Officer
2011
Brian Stolz
Valeant Pharmaceuticals International
Executive Vice President of Administration and Chief Human Capital Officer
2011
Rajiv De Silva
Valeant Pharmaceuticals International
Chief Operating Officer
2011
Mark Durham
Valeant Pharmaceuticals International
Senior Vice President, Human Resources
2011
Robert Chai-Onn
Valeant Pharmaceuticals International